Reproductive BioMedicine Online
Volume 21, Issue 5 , Pages 590-592 , November 2010

LH (as HCG) and FSH surges for final oocyte maturation: sometimes it takes two to tango?

  • Shahar Kol

      Affiliations

    • Rambam Medical Center, IVF Unit, Aliyah Street, Haifa, Israel
    • Corresponding Author InformationCorresponding author.
    • ,
  • Peter Humaidan

      Affiliations

    • The Fertility Clinic, Skive Regional Hospital, Resenvej 25, 7800 Skive, Denmark

Received 19 March 2010 ,Revised 25 May 2010 ,Accepted 16 June 2010.

References 

  1. Ascoli M, Fanelli F, Segaloff DL. The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr. Rev. 2002;23:141–174
  2. Balasch J, Fabregues F, Tur R, et al. Further characterization of the luteal phase inadequacy after gonadotrophin-releasing hormone agonist-induced ovulation in gonadotrophin-stimulated cycles. Hum. Reprod. 1995;10:1377–1381
  3. Damewood MD, Shen W, Zacur HA, et al. Disapperance of exogenously administered human chorionic gonadotropin. Fertil. Steril. 1989;52:398–400
  4. Eppig J. FSH stimulates hyaluronic acid synthesis by oocyte-cumulus complexes from mouse preovulatory follicle. Nature. 1979;281:483–486
  5. Fanchin R, Peltier E, Frydman R, de Ziegler D. Human chorionic gonadotropin: does it affect human endometrial morphology in vivo?. Semin. Reprod. Med. 2001;19:31–35
  6. Fatemi HM. The luteal phase after 3 decades of IVF: what do we know?. Reprod. Biomed. Online. 2009;19(Suppl. 1):4331
  7. Gonen Y, Balakier H, Powell W, Casper RF, et al. Use of GnRH agonist to trigger follicular maturation for in vitro fertilization. J. Clin. Endocrinol. Metab. 1990;71:918–922
  8. Hoff JD, Quigley ME, Yen SS. Hormonal dynamics at midcycle: a reevaluation. J. Clin. Endocrinol. Metab. 1983;57:792–796
  9. Humaidan P. GnRHa triggering of final oocyte maturation followed by one bolus of 1500IU hCG rescues the luteal phase and seems to prevent the risk of early onset OHSS in high-risk patients: a prospective proof-of-concept study. Reprod. Biomed. Online. 2009;18:630–634
  10. Humaidan P, Ejdrup Bredkjær H, Bungum L, et al. GnRH agonist (Buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomised study. Hum. Reprod. 2005;20:1213–1220
  11. Humaidan P, Bungum L, Bungum M, et al. Rescue of corpus luteum function with peri-ovulatory hCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study. Reprod. Biomed. Online. 2006;13:173–178
  12. Humaidan, P., Ejdrup Bredkjær, Westergaard, L., et al., 2009. 1500IU hCG administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized controlled study. Fertil. Steril. Feb 5. (Epub ahead of print).
  13. Imoedemhe DA, Sigue AB, Pacpaco EL, et al. Stimulation of endogenous surge of luteinizing hormone with gonadotropin-releasing hormone analog after ovarian stimulation for in vitro fertilization. Fertil. Steril. 1991;55:328–332
  14. Itskovitz J, Boldes R, Levron J, et al. Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist. Fertil. Steril. 1991;56:213–220
  15. Kolibianakis EM, Schultze-Mosgau A, Schroer A, et al. A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of hCG in patients undergoing IVF with GnRH antagonists. Hum. Reprod. 2005;20:2887–2892
  16. Oktay, K., Türkçüoglu, I., Rodriguez-Wallberg, K., 2009. A GnRHa trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor-FSH stimulation. Reprod. Biomed. Online, on web 30 Sep 2009.
  17. Schachter M, Friedler S, Ron-El R, et al. Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study. Fertil. Steril. 2008;90:1087–1093
  18. Segal S, Casper RF. Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin for triggering follicular maturation in in vitro fertilization. Fertil. Steril. 1992;57:1254–1258
  19. Shapiro BS, Daneshmand ST, Garner FC, et al. Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization. Fertil. Steril. 2008;90:231–233
  20. Stickland S, Beers W. Studies on the role of plasminogen activator in ovulation. In vitro response of granulosa cells to gonadotrophins, cyclic nucleotides and prostaglandins. J. Biol. Chem. 1976;251:5694–5699
  21. Sullivan MW, Stewart-Akers A, Krasnow JS, et al. Ovarian responses in women to recombinant follicle-stimulating hormone and luteinizing hormone (LH): a role for LH in the final stages of follicular maturation. J. Clin. Endocrinol. Metab. 1999;84:228–232
  22. Tavaniotou A, Devroey P. Effect of human chorionic gonadotropin on luteal luteinizing hormone concentrations in natural cycles. Fertil. Steril. 2003;80:654–655
  23. Tavaniotou A, Albano C, Smitz J, Devroey P. Comparison of LH concentrations in the early and mid-luteal phase in IVF cycles after treatment with HMG alone or in association with the GnRH antagonist Cetrorelix. Hum. Reprod. 2001;16:663–667
  24. Yding Andersen C. Effect of FSH and its different isoforms on maturation of oocytes from pre-ovulatory follicles. Reprod. Biomed. Online. 2002;5:232–239
  25. Yding Andersen C, Leonardsen L, Ulloa-Aguirre A, et al. FSH-induced resumption of meiosis in mouse oocytes: effect of different isoforms. Mol. Hum. Reprod. 1999;5:726–731
  26. Zelinski-Wooten MB, Hutchison JS, Hess DL, et al. Follicle stimulating hormone alone supports follicle growth and oocyte development in gonadotrophin-releasing hormone antagonist-treated monkeys. Hum. Reprod. 1995;10:1658–1666

PII: S1472-6483(10)00440-2

doi: 10.1016/j.rbmo.2010.06.031

Reproductive BioMedicine Online
Volume 21, Issue 5 , Pages 590-592 , November 2010

Article Tools